Novo, the maker of the obesity drug Wegovy, has repeatedly warned about the risks of compounded and knock-off versions of GLP ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

CEO Mike Doustdar shared the figure Monday at the J.P. Morgan Healthcare Conference, saying compounded versions have gained ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or ...

Speaking at the J.P. Morgan Healthcare Conference, Doustdar said compounders recognized consumer behavior earlier than major ...

Are compounded GLP-1s for weight loss safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

Importantly, a clinician should also ask about your mental health before prescribing a GLP-1. If you have a history of ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...